Curran Simpson insider trades

Open-market stock purchases and sales by Curran Simpson, Chief Executive Officer at REGENXBIO Inc, from SEC Form 4 filings since Jan 11, 2010.

Recent trades

DateStockTradeValue
Jul 1, 2026RGNX REGENXBIO IncSold (not open market)$89.2K
Jun 30, 2026RGNX REGENXBIO IncBought (not open market)$14.8K
Jan 6, 2026RGNX REGENXBIO IncBought (not open market)—
Jan 6, 2026RGNX REGENXBIO IncBought (not open market)—
Jan 2, 2026RGNX REGENXBIO IncSold (not open market)$267K
Dec 31, 2025RGNX REGENXBIO IncBought (not open market)$6.7K
Oct 9, 2025RGNX REGENXBIO IncSold$263K

Companies traded

  • RGNX REGENXBIO Inc: 28 sales, last Jul 1, 2026
  • HGSI Human Genome Sciences Inc: 27 sales, last Jul 30, 2012

Get free alerts when Curran Simpson files a new trade →